Evolent Health, Inc. (NYSE:EVH) Q2 2022 Earnings Conference Call August 2, 2022 5:00 PM ET

Company Participants

Seth Frank - Vice President, Investor Relations

Seth Blackley - Chief Executive Officer

John Johnson - Chief Financial Officer

Conference Call Participants

Ryan Daniels - William Blair

Sean Dodge - RBC Capital Markets

Anne Samuel - JPMorgan

Sandy Draper - Guggenheim

David Larsen - BTIG

Jessica Tassan - Piper Sandler

Richard Close - Canaccord Genuity

Charles Rhyee - Cowen

Operator

Good evening and welcome to Evolent Health's Earnings Conference for the Second quarter ended June 30th, 2022. Your hosts for the call today from Evolent Health are Seth Blackley, Chief Executive Officer, and John Johnson, Chief Financial Officer. All participants will be listen-only mode. [Operator Instructions] Please note this event is being recorded. This call will be archived and available beginning later this evening via the webcast on the company's Investor Relations website, which can be found at ir.evolenthealth.com.

I would now like to turn the conference over to Seth Frank, Evolent's Vice President of Investor Relations. Please go ahead.

Seth Frank

Thank you and good evening. This conference call will contain forward-looking statements under the US federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations.

A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to its second quarter press release issued earlier today.

Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in the summary presentation available in the Investor Relations section of our website, or in the company's press release issued today and posted on the IR section of the company's website, ir.evolenthealth.com, and the Form 8-K filed by the company with the SEC this afternoon.

During management's presentation and discussion, we will reference certain non-GAAP and GAAP figures and metrics that can be found in our earnings release, as well as a summary presentation available on the Events section of IR website, at ir.evolenthealth.com.

And now, I'll turn the call over to Evolent's CEO, Seth Blackley.

Seth Blackley

Good evening. Thank you for joining the call. I'll begin by summarizing our second quarter results and as always, provide my perspective on the status and progress of Evolent's three core operating priorities. John will discuss the numbers in more detail and share our updated guidance. And as always, we'll then take your questions at the end.